News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Zealand To Use Human Guinea Pigs For New Anti-Cancer Drug



12/21/2005 12:27:14 PM

New Zealand scientists said they had received approval to use humans in the first phase of clinical trials for a new anti-cancer drug. Ten patients in New Zealand and 20 overseas will take part in the first-stage trial for drug development company Proacta Therapeutics -- a subsidiary of US company Proacta -- using technology that aims to target tumours without damaging other tissue. Cancer specialist Michael Jameson said in a statement on Wednesday, there were risks involved in trialling a new anti-cancer compound and only about one in every 20 or 25 people could expect good tumour shrinkage. The drug stems from 23 years of work by two New Zealand scientists, Bill Denny and Bill Wilson, aimed at killing cancer cells while leaving healthy cells intact.

Read at AFP
Read at New Zealand Herald
Read at Times of India


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES